Osteonecrosis and Haemostasis (SW19-05-23-1)

AvailabilityCourse has taken place
Documents
Programme

Need help viewing PDF documents?

SubjectOral Surgery
DescriptionVinod Patel (Consultant Oral Surgeon,Guys Hospital) will be coming to Bath to discuss arguably the two most important things we face in general practice, Osteonecrosis and Haemostasis. Vinod will provide an update on Osteonecrosis of the jaw including; Medication Related Osteonecrosis, bisphonates, desumab and new drugs, osteoradionecrosis and the management of patients at risk or with established Osteonecrosis. He will guide us through medications affecting haemostasis, and discuss the management of an intra oral bleed. All members of the dental team are very welcome. This course is suitable for PVLE Candidates.
Additional information

This is the first of two courses in Bath today - you are welcome to come to both or attend just the morning session.  If you are planning to stay all day - you will need to also book 'Contemporary Management of Third Molars'.

To keep costs to a minimum, lunch will not be provided. There is a café at the Royal United Hospital - or you might want to bring a packed lunch if you are staying for both courses.

VenuePostgraduate Medical Centre, Bath - Bath & NE Somerset  View details
Date & timeThursday 23 May 2019, 10:00 to 13:00
LecturerDr Vinod Patel  View details
Target audience

Recommended to all

Development outcomeC
Course styleLecture
Catering Tea and coffee only
Core topic Not a core topic
CPD hours3:00
Cost£25.00
Aims
  • To update delegates on bisphosphonates, new anti-resorptive bone agents and anti-angiogenic medications, their mechanisms of action and indication for prescription
  • To update delegates on medications affecting haemostasis 
  • Enable practitioners to identify which patients are at risk, and should be referred to secondary care
Objectives
  • To be able to identify the various drugs implicated in medication related osteonecrosis of the jaw
  • To determine those patients at risk of osteonecrosis
  • To recognise a differing approach to treating patients at risk of necrosis
  • To recognise the likely risk of osteonecrosis in the future
  • To recognise medications that alter regular haemostasis
  • To be able to surgically manage patients taking haemostasis altering medication
  • To provide an appropriate intervention in a post operative emergency bleed
Learning outcomes

For delegates to know what the risks for medication-related osteonecrosis of the jaw (MRONJ) and post operative bleeding are, how to manage the risks, and when to refer to secondary care. Delegates will also gain an understanding of the secondary care management of these patients.